These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20736374)

  • 21. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
    Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
    J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells.
    Rossignol P; Ho-Tin-Noé B; Vranckx R; Bouton MC; Meilhac O; Lijnen HR; Guillin MC; Michel JB; Anglés-Cano E
    J Biol Chem; 2004 Mar; 279(11):10346-56. PubMed ID: 14699093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
    Biliran H; Sheng S
    Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
    Inuzuka K; Ogata Y; Nagase H; Shirouzu K
    J Surg Res; 2000 Oct; 93(2):211-8. PubMed ID: 11027463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulant and antithrombotic properties of platelet protease nexin-1.
    Boulaftali Y; Adam F; Venisse L; Ollivier V; Richard B; Taieb S; Monard D; Favier R; Alessi MC; Bryckaert M; Arocas V; Jandrot-Perrus M; Bouton MC
    Blood; 2010 Jan; 115(1):97-106. PubMed ID: 19855083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
    Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
    Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade.
    Le DM; Besson A; Fogg DK; Choi KS; Waisman DM; Goodyer CG; Rewcastle B; Yong VW
    J Neurosci; 2003 May; 23(10):4034-43. PubMed ID: 12764090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
    Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
    Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of tumor growth by β-elemene through downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9 in a murine intraocular melanoma model.
    Shi H; Liu L; Liu LM; Geng J; Chen L
    Melanoma Res; 2015 Feb; 25(1):15-21. PubMed ID: 25405459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.
    Luparello C; Sirchia R; Pupello D
    J Cell Sci; 2003 Jun; 116(Pt 12):2421-30. PubMed ID: 12724357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
    Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M
    Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of the heparin and low density lipid receptor-related protein-binding sites of protease nexin 1 (PN1) in urokinase-PN1 complex catabolism. The PN1 heparin-binding site mediates complex retention and degradation but not cell surface binding or internalization.
    Crisp RJ; Knauer DJ; Knauer MF
    J Biol Chem; 2000 Jun; 275(26):19628-37. PubMed ID: 10867020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of extracellular plasminogen activator by human fibroblasts. The role of protease nexin.
    Scott RW; Eaton DL; Duran N; Baker JB
    J Biol Chem; 1983 Apr; 258(7):4397-403. PubMed ID: 6339496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of ERK signaling upon alternative protease nexin-1 internalization mediated by syndecan-1.
    Li X; Herz J; Monard D
    J Cell Biochem; 2006 Oct; 99(3):936-51. PubMed ID: 16741952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.
    Tan X; Egami H; Nozawa F; Abe M; Baba H
    Int J Oncol; 2006 Feb; 28(2):369-74. PubMed ID: 16391791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation.
    Hägglund AC; Ny A; Liu K; Ny T
    Endocrinology; 1996 Dec; 137(12):5671-7. PubMed ID: 8940398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.
    Nalla AK; Gorantla B; Gondi CS; Lakka SS; Rao JS
    Cancer Gene Ther; 2010 Sep; 17(9):599-613. PubMed ID: 20448670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
    He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X
    Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.